19 May 2013
Keywords: kissei, starts, phase, trials, kvx-478, pharmaceutical, started
Article | 29 May 1995
- Kissei Pharmaceutical has started Japanese Phase I trials of KVX-478,
an oral protease inhibitor for treating HIV infection licensed from
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 1995
17 May 2013
© 2013 thepharmaletter.com